STOCK TITAN

Waters - WAT STOCK NEWS

Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.

Waters Corporation (NYSE: WAT), a global leader in analytical instrumentation and laboratory technologies, provides critical solutions for pharmaceutical development, food safety testing, and environmental monitoring. This dedicated news hub aggregates official announcements, financial disclosures, and strategic updates directly impacting the company's market position and technological advancements.

Investors and industry professionals will find curated updates including quarterly earnings reports, product innovation announcements, executive leadership changes, and regulatory developments. Our repository ensures timely access to filings, partnership agreements, and scientific breakthroughs related to Waters' chromatography systems, mass spectrometry platforms, and thermal analysis instruments.

Key content categories include financial performance updates, new product launches, research collaborations, and operational expansions. Bookmark this page to monitor developments affecting Waters' role in life sciences R&D, quality assurance protocols, and laboratory informatics solutions across 100+ countries.

Rhea-AI Summary
Waters Corporation introduces the DynaPro ZetaStar instrument for nanoparticle analysis, combining three light scattering techniques into a single device. The instrument cuts measurement time by up to 10x and improves efficiency and confidence in results. It supports workflows in gene therapy, vaccines, mRNA, proteins, and R&D laboratories. The ZetaStar instrument allows for simultaneous DLS and ELS measurements and collects five critical parameters in a single workflow. It can be configured with an autosampler for unattended measurements. The instrument's novel algorithm removes user error and bias, improving implementation and time to results. It supports the needs of biopharma formulation and development laboratories and material science R&D. The integration of Waters and Wyatt has reached an exciting milestone with the introduction of the ZetaStar instrument as the first new product from the combined companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
none
-
Rhea-AI Summary
Waters Corporation unveils new bioprocess walk-up solutions to simplify sample prep and analysis, accelerating upstream bioprocess development by up to six weeks. The integrated software and automation eliminate manual steps and reduce human errors, leading to lower downstream costs for manufacturing and drug product prices for patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
none
-
Rhea-AI Summary
Waters Corp CEO to participate in fireside chat at Bank of America Global Healthcare Conference in London on Sept 13th
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
conferences
Rhea-AI Summary
Waters Corporation (NYSE: WAT) announced its Q2 2023 financial results, reporting $741 million in sales, a 4% increase. The company saw strength in the Industrial and Academic & Government sectors, with high single-digit growth in the U.S. and Europe. However, Pharma sales in China were weak. The Wyatt acquisition contributed 2% growth in the quarter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.33%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.04%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
Waters

NYSE:WAT

WAT Rankings

WAT Stock Data

19.10B
59.40M
0.08%
96.91%
2.72%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
MILFORD